CryoPort, Inc. provides cryogenic logistics solutions to the life sciences industry in the United States, Europe, Asia, and internationally. The company offers Cryoportal, a cloud-based logistics management software that automates the entry of orders, prepares customs documentation, and facilitates status and location monitoring of shipped orders while in transit; and CryoPort Express Shippers, which are dry cryogenic shippers that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. It also provides Cryoport Express Standard Shippers, which are re-usable dry vapor liquid nitrogen storage containers for holding the biological material in the inner chamber; CryoPort Express High Volume Shippers, which use a dry vapor liquid nitrogen technology to maintain temperatures; and Cryoport Express CXVC1 Shippers that provides solutions related to the shipment of time- and temperature-critical, as well as frozen and refrigerated transport of biological materials, such as stem cells, cell lines, pharmaceutical clinical trial samples, gene biotechnology, infectious materials handling, animal, and human reproduction. In addition, the company offers CryoPort Express Smart Pak, a self-contained automated data logger, which records cryogenic temperatures of samples shipped in CryoPort Express Shippers; CryoPort Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric; and biological material holders that are containment bags used in connection with the shipment of infectious or dangerous goods using the CryoPort Express Shippers. CryoPort, Inc. has a strategic alliance with Liventa Bioscience, Inc. The company was founded in 1999 and is based in Lake Forest, California.